On June 07, 2007 world’s leading pharmaceutical company Pfizer filed a patent infringement complaint in the US District Court for the District of Delaware against Teva Pharmaceutical Industries alleging infringement of the US Patent No. 5,273,995 (the ‘995 patent) in response to Teva submission of Abbreviated New Drug Application (ANDA) No. 78-773 with US FDA for generic Lipitor tablets seeking marketing approval prior to the expiration of the ‘995 patent. With this Teva has joined Ranbaxy in a million-dollar generic Lipitor battle!
No comments:
Post a Comment